Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Abrau Club will be developed by an ex-minority shareholder of Magnit

5/2/24 ABRD

UTair sold 91.08% in Peruvian Helicopteros

5/2/24 UTAR

Severstal reported for the 3 months of 2024 by RAS

5/2/24 CHMF

Court rejects DIA's request to reverse QIWI's asset sale deal

5/2/24 QIWI

RusAgro to pay for 25% of Agro-Belogorie ₽2.5 thousand

5/2/24 RAGR

Mostotrest reported for 2023 by IFRS

5/2/24 MSTT

TNS Energy Yaroslavl reported for 2023 by IFRS

5/2/24 YRSB

Abrau-Durso reported for 2023 by IFRS

5/2/24 ABRD

Rosinter reported for 3 months of 2024 by RAS

5/2/24 ROST

M.video will sell refurbished devices

5/2/24 MVID